Instil Bio Stock Math Transform Inverse Tangent Over Price Movement

TIL Stock  USD 8.75  -0.28  -3.10%   
This math transform tool runs Inverse Tangent Over Price Movement transformation and companion studies for Instil Bio. It emphasizes price transformations that reveal shifts in trend structure while keeping volatility, risk, and performance context in view.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Instil Bio Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Instil Bio price patterns.

Instil Bio Technical Analysis Modules

Most technical analysis of Instil Bio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Instil from various momentum indicators to cycle indicators. When you analyze Instil charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas. Instil Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 463 people. Liquidity and trading activity can influence how quickly new information is reflected in Instil Bio's price. Lower trading activity may introduce occasional variability in execution conditions. Instil Bio has a market cap of 61.24 M, P/E of 18.31, ROE of -50.6%.

Methodology

Unless otherwise specified, financial data for Instil Bio is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Instil (USA Stocks:TIL) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report is built using public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Normalization for analytical consistency may introduce small timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Instil Bio may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board

Learn to be your own money manager

Tracking Instil Bio inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

Instil Bio pair trading

Pair trading with Instil Bio can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Instil Bio Pair Trading

Instil Bio Pair Trading Analysis

Finding correlated alternatives to Instil Bio is a practical necessity for tax-aware investors. The wash-sale rule prohibits repurchasing Instil Bio within 30 days of a loss sale, making it essential to identify substitute holdings with similar risk profiles.
The statistical relationship between Instil Bio and other instruments is summarized by the correlation coefficient. Investors use this measure to identify whether adding a new position would truly diversify a portfolio already containing Instil Bio.
Use Correlation analysis and pair trading evaluation for Instil Bio to review hedging context. The approach can be applied within sectors or across broader universes.
Pair CorrelationCorrelation Matching

More Resources for Instil Stock Analysis

Understanding Instil Bio typically begins with financial statements and long-term trend review. Ratio context helps frame profitability, efficiency, and growth trends for Instil Bio Stock. Outlined below are key reports that provide context for Instil Bio Stock:
Instil Bio has a market cap of 61.24 M, ROE of -50.6%. Review World Market Map for broader portfolio context. This reflects a position in Instil Bio within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
New to investing in Instil Stock? Start with our How to Invest in Instil Stock guide for a step-by-step overview.
Analysis related to Instil Bio should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
 Earnings Share
-11.35
 Return On Assets
-0.15
 Return On Equity
-0.51
Instil Bio's market price can diverge from book value, the accounting figure shown on Instil's balance sheet. Instil Bio's market capitalization is 61.24 M. A P/B ratio of 0.51 suggests Instil Bio trades near or below book value. Enterprise value stands at 66.49 M. Intrinsic value reflects what Instil Bio's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
It is useful to distinguish Instil Bio's value from its trading price, which are computed with different methods. For Instil Bio, key inputs include a P/E ratio of 18.31, a P/B ratio of 0.51, and ROE of -50.6%. The quoted price is simply the exchange level where supply meets demand.